Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7,853 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial.
Nishimura R, Rai Y, Matsuo F, Anan K, Hara S, Imamura S, Itoyanagi N, Kato M, Okido M, Kudaka M, Ishikawa E, Kamada Y, Watanabe R, Shirouzu M, Mitsuyama S, Takamatsu Y, Tamura K. Nishimura R, et al. Among authors: kato m. Anticancer Res. 2012 Aug;32(8):3259-65. Anticancer Res. 2012. PMID: 22843900 Clinical Trial.
7,853 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page